Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections.

Allan-Blitz LT, Klausner JD

Open source

DOI
10.1017/ash.2026.10940
Published
2026
Container
Antimicrobial stewardship & healthcare epidemiology : ASHE
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/ash.2026.10940,
  title = {Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections.},
  author = {Allan-Blitz LT and Klausner JD},
  year = {2026},
  journal = {Antimicrobial stewardship \& healthcare epidemiology : ASHE},
  doi = {10.1017/ash.2026.10940},
  url = {https://doi.org/10.1017/ash.2026.10940}
}

RIS

TY  - JOUR
TI  - Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections.
AU  - Allan-Blitz LT
AU  - Klausner JD
PY  - 2026
JO  - Antimicrobial stewardship & healthcare epidemiology : ASHE
DO  - 10.1017/ash.2026.10940
UR  - https://doi.org/10.1017/ash.2026.10940
ER  - 

APA

LT, A., & JD, K. (2026). Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections.. Antimicrobial stewardship & healthcare epidemiology : ASHE. https://doi.org/10.1017/ash.2026.10940

Source records